Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials

por Mouillet, Guillaume, Efficace, Fabio, Thiery‐Vuillemin, Antoine, Charton, Emilie, Van Hemelrijck, Mieke, Sparano, Francesco, Anota, Amélie
Publicado 2020

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

por Calcagno, Fabien, Nguyen, Thierry, Dobi, Erion, Villanueva, Cristian, Curtit, Elsa, Kim, Stefano, Montcuquet, Philippe, Kleinclauss, François, Pivot, Xavier, Thiery-Vuillemin, Antoine
Publicado 2012

Post Hoc Health‐Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies

por Thiery‐Vuillemin, Antoine, Fizazi, Karim, Sartor, Oliver, Oudard, Stéphane, Bury, Denise, Ozatilgan, Ayse, Poole, Elizabeth M., Eisenberger, Mario, de Bono, Johann
Publicado 2021

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

por CAUBET, MATTHIEU, DOBI, ERION, POZET, ASTRID, ALMOTLAK, HAMADI, MONTCUQUET, PHILIPPE, MAURINA, TRISTAN, MOUILLET, GUILLAUME, N'GUYEN, THIERRY, STEIN, ULRICH, THIERY-VUILLEMIN, ANTOINE, FITENI, FREDERIC
Publicado 2015

Efficacy of trabectedin in metastatic solitary fibrous tumor

por Chaigneau, Loïc, Kalbacher, Elsa, Thiery-Vuillemin, Antoine, Fagnoni-Legat, Christine, Isambert, Nicolas, Aherfi, Lionel, Pauchot, Julien, Delroeux, Delphine, Servagi-Vernat, Stephanie, Mansi, Laura, Pivot, Xavier
Publicado 2011

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported o...

por Mouillet, Guillaume, Fritzsch, Joëlle, Paget-Bailly, Sophie, Pozet, Astrid, Es-Saad, Ikram, Meurisse, Aurelia, Vernerey, Dewi, Mouyabi, Kristina, Berthod, Diane, Bonnetain, Franck, Anota, Amélie, Thiery-Vuillemin, Antoine
Publicado 2019

Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in p...

por Mouillet, Guillaume, Paillard, Marie-Justine, Maurina, Tristan, Vernerey, Dewi, Nguyen Tan Hon, Thierry, Almotlak, Hamadi, Stein, Ulrich, Calcagno, Fabien, Berthod, Diane, Robert, Elise, Meurisse, Aurelia, Thiery-Vuillemin, Antoine
Publicado 2018

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URo...

por Coquan, Elodie, Clarisse, Bénédicte, Lequesne, Justine, Brachet, Pierre-Emmanuel, Nevière, Zoé, Meriaux, Emeline, Bonnet, Isabelle, Castera, Marie, Goardon, Nicolas, Boutrois, Jeremy, Travers, Romain, Joly, Florence, Grellard, Jean-Michel, Thiery-Vuillemin, Antoine
Publicado 2022

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma

por Nerich, Virginie, Hugues, Marion, Paillard, Marie Justine, Borowski, Laëtitia, Nai, Thierry, Stein, Ulrich, Nguyen Tan Hon, Thierry, Montcuquet, Philippe, Maurina, Tristan, Mouillet, Guillaume, Kleinclauss, François, Pivot, Xavier, Limat, Samuel, Thiery-Vuillemin, Antoine
Publicado 2014

Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the ob...

por Thiery-Vuillemin, Antoine, Hvid Poulsen, Mads, Lagneau, Edouard, Ploussard, Guillaume, Birtle, Alison, Dourthe, Louis-Marie, Beal-Ardisson, Dominique, Pintus, Elias, Trepiakas, Redas, Antoni, Laurent, Lukac, Martin, Van Sanden, Suzy, Pissart, Geneviève, Reid, Alison
Publicado 2018

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer

por Carr, T. Hedley, Adelman, Carrie, Barnicle, Alan, Kozarewa, Iwanka, Luke, Sally, Lai, Zhongwu, Hollis, Sally, Dougherty, Brian, Harrington, Elizabeth A., Kang, Jinyu, Saad, Fred, Sala, Nuria, Thiery-Vuillemin, Antoine, Clarke, Noel W., Hodgson, Darren, Barrett, J. Carl
Publicado 2021

PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers

por Teyssonneau, Diego, Thiery-Vuillemin, Antoine, Dariane, Charles, Barret, Eric, Beauval, Jean-Baptiste, Brureau, Laurent, Créhange, Gilles, Fiard, Gaëlle, Fromont, Gaëlle, Gauthé, Mathieu, Ruffion, Alain, Renard-Penna, Raphaële, Mathieu, Romain, Sargos, Paul, Rouprêt, Morgan, Ploussard, Guillaume, Roubaud, Guilhem
Publicado 2022

Impact on Health‐Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial

por Bouleuc, Carole, Anota, Amélie, Cornet, Cécile, Grodard, Ghislain, Thiery‐Vuillemin, Antoine, Dubroeucq, Olivier, Crétineau, Nathalie, Frasie, Véronique, Gamblin, Vincent, Chvetzoff, Gisèle, Favier, Laure, Tournigand, Christophe, Grach, Marie‐Christine, Raynard, Bruno, Salas, Sébastien, Capodano, Géraldine, Pazart, Lionel, Aubry, Régis
Publicado 2020

Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound

por Chi, Kim N., Barnicle, Alan, Sibilla, Caroline, Lai, Zhongwu, Corcoran, Claire, Barrett, J. Carl, Adelman, Carrie A., Qiu, Ping, Easter, Ashley, Dearden, Simon, Oxnard, Geoffrey R., Agarwal, Neeraj, Azad, Arun, de Bono, Johann, Mateo, Joaquin, Olmos, David, Thiery-Vuillemin, Antoine, Harrington, Elizabeth A.
Publicado 2023

Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair ge...

por Smith, Matthew R, Sandhu, Shahneen, George, Daniel J, Chi, Kim Nguyen, Saad, Fred, Thiery-Vuillemin, Antoine, Stàhl, Olaf, Olmos, David, Danila, Daniel C, Gafanov, Rustem, Castro, Elena, Moon, Helen, Joshua, Anthony M, Mason, Gary E, Espina, Byron M, Liu, Yan, Lopez-Gitlitz, Angela, Francis, Peter, Bevans, Katherine B, Fizazi, Karim
Publicado 2023

REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study

por Vauchier, Charles, Auclin, Edouard, Barthélémy, Philippe, Carril-Ajuria, Lucia, Ryckewaert, Thomas, Borchiellini, Delphine, Castel-Ajgal, Zahra, Bennamoun, Mostefa, Campedel, Luca, Thiery-Vuillemin, Antoine, Coquan, Elodie, Crouzet, Laurence, Berdah, Jean-François, Chevreau, Christine, Ratta, Raffaele, Fléchon, Aude, Lefort, Felix, Albiges, Laurence, Gross-Goupil, Marine, Vano, Yann-Alexandre, Thibault, Constance, Oudard, Stéphane
Publicado 2022